182 related articles for article (PubMed ID: 36672781)
41. Sarcopenia and a 5-mRNA risk module as a combined factor to predict prognosis for patients with stomach adenocarcinoma.
Yang H; Tian W; Zhou B
Genomics; 2022 Jan; 114(1):361-377. PubMed ID: 34933074
[TBL] [Abstract][Full Text] [Related]
42. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
43. Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods.
Liu J; Zhou M; Ouyang Y; Du L; Xu L; Li H
PeerJ; 2020; 8():e9174. PubMed ID: 33062405
[TBL] [Abstract][Full Text] [Related]
44. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
[TBL] [Abstract][Full Text] [Related]
45. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
Luo N; Fu M; Zhang Y; Li X; Zhu W; Yang F; Chen Z; Mei Q; Peng X; Shen L; Zhang Y; Li Q; Hu G
Front Cell Dev Biol; 2022; 10():935135. PubMed ID: 35859893
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
Wang Z; Wang K; Yu X; Chen M; Du Y
J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
[No Abstract] [Full Text] [Related]
47. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
48. JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma.
Meng L; Ding L; Yu Y; Li W
Biomed Res Int; 2020; 2020():7973568. PubMed ID: 33083484
[TBL] [Abstract][Full Text] [Related]
49. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
Fan Z; Wang Y; Niu R
Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer.
Yang Y; Zhou L; Gou X; Wu G; Zheng Y; Liu M; Chen Z; Wang Y; Ji R; Guo Q; Zhou Y
Math Biosci Eng; 2022 Jan; 19(1):595-611. PubMed ID: 34903003
[TBL] [Abstract][Full Text] [Related]
52. Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma.
Zhu D; Wu S; Li Y; Zhang Y; Chen J; Ma J; Cao L; Lyu Z; Hou T
Cancer Cell Int; 2022 Mar; 22(1):124. PubMed ID: 35305616
[TBL] [Abstract][Full Text] [Related]
53. Increased ANXA5 expression in stomach adenocarcinoma infers a poor prognosis and high level of immune infiltration.
Su Z; Shu K; Li G
Cancer Biomark; 2022; 35(2):155-165. PubMed ID: 35912732
[TBL] [Abstract][Full Text] [Related]
54. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
[TBL] [Abstract][Full Text] [Related]
55. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
56. Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.
Zhang L; Zhang Q; Huang Z; Zhu M; Wang T; Zhu W; Wang X; Zhou X
Biomed Res Int; 2022; 2022():2053719. PubMed ID: 36193316
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma.
Huang Z; He A; Wang J; Lu H; Xu X; Zhang R; Liao W; Feng Q; Wu L
Cancer Biomark; 2022; 34(1):77-93. PubMed ID: 34657879
[TBL] [Abstract][Full Text] [Related]
59. Development of a prognostic metabolic signature in stomach adenocarcinoma.
Gong Y; Wu S; Dong S; Chen S; Cai G; Bao K; Yang H; Jiao Y
Clin Transl Oncol; 2022 Aug; 24(8):1615-1630. PubMed ID: 35355155
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
